Saved To My Saved Content

Some of the largest companies on the planet seem to defy gravity. They keep innovating—and keep growing—long after many of their peers lose momentum. Perhaps even more remarkably, they continue to do this despite operating in one of the most challenging business environments in decades.  

Often, what sets these companies apart isn’t a string of blockbuster acquisitions or a portfolio of moonshots. It’s their ability to harness innovation and continually reinvent their core business to drive the next generation of growth.

We call this vitality—our proprietary measure of a company's future growth potential. This year’s BCG Vitality Index assessed more than 3,500 companies over five years to understand how large-cap vitality leaders, such as L'Oréal and MercadoLibre, translate innovation in their existing businesses into sustained growth. (See the sidebar, “Methodology.”)

Methodology
The concept of vitality as a model for predicting future growth was originally conceived by the BCG Institute, BCG’s think tank, and has been refined over many years. 

The 2026 edition of our vitality report includes the latest developments and is the product of rigorous testing, with more than 30 variables assessed for statistical significance in a five-year historical model.   

The vitality index integrates some 10 million data points drawn from high-quality sources. For example, to understand what the organizations look like, we turned to Revelio Labs; and to understand organizations’ tech quality, we relied on HG Insights.

The composite vitality score represents a holistic capability built from 15 individual, weighted metrics associated with long-term revenue growth.  

Our sample is global and spans industries, business models, and geographies. It encompasses both public firms (with a market exceeding $5 billion, based on S&P Capital IQ screening) and private firms (with more than $1 billion in funding, based on Pitchbook screening). Data is current as of January 1, 2026. We use a standardized methodology to track companies, enabling robust comparisons across industries, geographies, and years.  

We made use of AI tools for some parts of the report, using natural language processing to score some data, and in a few cases using GenAI to surface missing data.  

Five Actions That CEOs Can Take to Increase Vitality

Reinventing the core is becoming increasingly important as higher capital costs and intensified investor scrutiny of ROI prompt companies to rethink and resize noncore initiatives. From 2024 to 2026, the share of innovation budgets allocated to core initiatives increased by 12 percentage points while investment in adjacent and transformational bets declined, according to BCG research.1 1 BCG Innovation to Impact (i2i) Database, 2026.

As companies place bigger bets on the core, the challenge for CEOs is to know whether those investments will deliver future growth. Until now, CEOs have had to rely on traditional performance metrics that are predominantly backward-looking. BCG’s vitality metric, by contrast, is a forward-looking indicator that can help them better assess whether their core innovation investments today are positioning their business to outperform in the years ahead.

No CEO needs to settle for low vitality. Because companies can measure it at a granular level, they can actively manage and strengthen it. In this year’s study, one in three companies increased their vitality score by at least 10 percentage points relative to industry peers.

The rewards of improving vitality are substantial. Companies with above-median scores in our study achieved annual revenue growth that was 5.2 percentage points higher over the ensuing five years than that of their less vital peers. Companies that started with low vitality but improved it over the same period earned an additional 6.8 percentage points in annual total shareholder return (TSR) compared to the rest of the companies in the study. The upshot: vital companies are both great businesses and great stocks.

In this report, we examine 25 vitality leaders and what they have in common. We also distill five actions CEOs can take to build and improve vitality within their own organization.

The 2026 Large Cap Vitality Leaders
We are spotlighting 25 vital companies with market caps of $25 billion or more. Explore the full list below to learn more about each firm’s industry and the vitality characteristics that make each company stand out.
Vitality-Report-2026-cover-slide.jpg

What Vital Companies Do Differently

CEOs and their teams spend enormous energy deciding where to play—which markets to enter, which technologies to back, and which acquisitions to pursue. But those choices don’t answer an equally important question: How will you win?

The most vital companies don't succeed because they have bigger innovation budgets or more ambitious venture portfolios. They win by fostering strategic, human, and cultural traits that enable them to drive sustained growth.

To unpack what sets these companies apart, we identified 15 variables—biomarkers of vitality—that consistently cluster into three reinforcing traits:

Biomarkers of Vitality

Icon-Lightbulb.png
High Growth Ambition
Head-Man-Gear-icon.svg
High Talent Density
Cardiology.svg
Growth-Centric Culture
Icon-Lightbulb.png
High Growth Ambition
Head-Man-Gear-icon.svg
High Talent Density
Cardiology.svg
Growth-Centric Culture

No company becomes highly vital by excelling in just one of these areas. The companies that consistently outperform their peers build strength across all three, creating a flywheel that grows more robust over time. An exciting ambition attracts strong performers, which builds higher talent density and pushes the organization to reinvent itself. These teams challenge prevailing cultural notions of what is possible and accelerate innovation, and this in turn gives leaders greater confidence to level up their own ambitions for growth.

The growth flywheel is especially valuable for large enterprises. Among companies in our study whose market caps exceed $25 billion, those in the highest vitality quartile achieved 11.5% annual revenue growth over five years, compared with an average of 6.6% for large companies overall. (See the exhibit.) They also generated annual TSR at a rate that was 3.1 percentage points higher than that of large companies in the lowest vitality quartile.

Vitality Is Especially Valuable for Large Firms

Building this kind of advantage isn’t accidental. It requires having leaders who know where their vitality is strongest, where it’s weakest, and which actions they should take to deliver the greatest growth impact.

Weekly Insights Subscription
Stay ahead with BCG insights on innovation strategy and delivery


Five Actions That CEOs Can Take to Increase Vitality

Vitality is not static. It is something that organizations can actively measure and deliberately strengthen, refine, and renew.

The 25 vitality leaders featured in this year’s report show what that looks like in practice. These companies span industries, geographies, and business models—from high-growth disruptors to established companies in traditionally slower-growing sectors. What they have in common are five actions that consistently strengthen their capacity for future growth.

Move from the Edge to the Core

For much of the past decade, many companies pursued innovation at the edges of the organization, through incubators, venture funds, digital labs, and corporate venture capital. Those investments produced important ideas, but in many cases they were disconnected from the businesses that generated the lion’s share of the company’s growth.

The vitality leaders in our research take a different approach. They treat the core business—not the edge—as their primary engine of innovation. They expect every business unit to identify, build, and scale new sources of growth. Rather than delegating innovation to a separate team, they embed it in how the company competes.

Eaton, a century-old power management giant, shows what’s possible, improving its score by an impressive 50 percentage points over five years. This remarkable boost in vitality reflects the company’s efforts to reshape its portfolio, divest noncore businesses (lighting, hydraulics, and, soon, mobility), and reinvest in higher-growth opportunities. During the same period, Eaton delivered 23.9% annual TSR, compared with the industry median of 13.4%.

Measure Vitality Like Any Other Critical KPI

Leaders in vitality treat it with the same discipline that they apply to revenue, margins, and cash flow. Instead of waiting for financial results to reveal whether today’s decisions are working, they monitor all 15 variables across the three vitality traits and adjust course before small gaps become large ones.

Create Clear Ownership and Accountability

Vitality doesn't belong to an innovation team, an R&D function, or a strategy department. It cuts across the entire enterprise, which means that responsibility for improvement can easily become fragmented. That’s why it calls for an executive owner with a clear mandate and a common fact base that can help the senior leadership team to align on where the company’s growth ambition, talent density, and growth-centric culture are strongest, where they are falling behind, and where leadership intervention will have the greatest impact.

In some organizations, that owner will be the CEO. In others, the role naturally sits with the chief financial officer or the chief strategy officer. Either way, vitality extends the strategy agenda beyond planning, budgeting, and discrete transformation initiatives. It gives leadership a practical way to challenge priorities, align investment decisions, and hold the organization accountable for building the capabilities needed to drive future growth.

Identify and Close the Most Important Vitality Gaps

The most vital companies don’t try to improve every biomarker simultaneously. They identify the few that matter most in their competitive context—the ones most likely to constrain future growth—and focus leadership attention and investment there.

L'Oréal provides a strong example of this discipline. Over the past five years, by pulling a few key levers, the company climbed 26 percentile points to emerge as vitality leader among large firms in the beauty space. Top-quartile scores in R&D momentum and innovator density reflect the fruits of over €1.3 billion in annual R&D spending, which L'Oréal describes as the largest research effort in the cosmetics industry. The company combined this strength with targeted investments in digital innovation (such as its CreAItech content lab and its Cell BioPrint “lab-on-a-chip” diagnostic device) to spur continued regenerative growth. As a result, L'Oréal has one or two core strengths across each of the three dimensions, positioning it to drive regenerative growth without spreading itself thin trying to fix all 15 biomarkers at once.

Embed Vitality in Enterprise Transformation

Vitality leaders don’t treat the task of embedding vitality as just another transformation initiative. They use vitality as an organizing framework for transformation itself, by ensuring that the three bedrock capabilities—growth ambition, talent density, and a growth-centric culture—reinforce one another rather than competing for attention.

Leaders don’t overinvest in one dimension at the expense of others, which is why top vitality performers are nearly ten times as likely as low performers to rank in the top quartile on at least one variable across all three core vitality capabilities.

MercadoLibre demonstrates the power of this approach. Over the past five years, the company has maintained its high level of vitality (98th percentile within its industry in 2026) despite growing in size. It has also supported its core business through targeted bolt-ons in fintech, logistics, advertising, and AI-powered services. Rather than investing only in new products, MercadoLibre has simultaneously built the teams, technology, operating capabilities, and culture it needed to scale those businesses together, helping it remain one of the highest-vitality companies in its industry.

The companies featured in this report—and all 25 featured vitality leaders—demonstrate the same principle: sustained growth comes from strengthening all three vitality traits as a whole, rather than optimizing individual parts. They also illustrate that CEOs can deliberately build and strengthen vitality over time. In a world where impressive growth is harder to achieve, the companies that pull ahead will be those that consistently reinvent their core business and turn that renewal into the next generation of growth.